3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with mdl 100907 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balducci, C; Baviera, M; Invernizzi, RW; Mirjana, C | 1 |
| Baviera, M; Calcagno, E; Carli, M; Ceglia, I; Invernizzi, RW; Renoldi, G | 1 |
| Balducci, C; Baviera, M; Carli, M; Invernizzi, RW | 1 |
| Baviera, M; Calcagno, E; Carli, M; Invernizzi, RW | 1 |
| Agnoli, L; Carli, M | 1 |
5 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and mdl 100907
| Article | Year |
|---|---|
The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.
Topics: Animals; Attention; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluorobenzenes; Injections, Subcutaneous; Male; Microinjections; Motor Activity; Piperazines; Piperidines; Prefrontal Cortex; Psychomotor Performance; Rats; Reaction Time; Receptor, Serotonin, 5-HT2A; Receptors, N-Methyl-D-Aspartate; Serial Learning; Serotonin Antagonists | 2004 |
The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.
Topics: 2-Amino-5-phosphonovalerate; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Extracellular Space; Fluorobenzenes; Glutamic Acid; Male; Microdialysis; Nicotine; Piperazines; Piperidines; Potassium Chloride; Prefrontal Cortex; Rats; Receptor, Serotonin, 5-HT2A; Receptors, N-Methyl-D-Aspartate; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Tetrodotoxin | 2004 |
Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Attention; Behavior, Animal; Choice Behavior; Compulsive Behavior; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fluorobenzenes; Impulsive Behavior; Male; Piperazines; Piperidines; Prefrontal Cortex; Pyridines; Rats; Reaction Time; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, N-Methyl-D-Aspartate; Serotonin Antagonists; Serotonin Receptor Agonists | 2006 |
Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.
Topics: Animals; Behavior, Animal; Cerebral Cortex; Chromatography, High Pressure Liquid; Ethylamines; Excitatory Amino Acid Antagonists; Fluorobenzenes; Glutamic Acid; Indoles; Male; Microdialysis; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, N-Methyl-D-Aspartate; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists; Time Factors | 2009 |
Dorsal-striatal 5-HT₂A and 5-HT₂C receptors control impulsivity and perseverative responding in the 5-choice serial reaction time task.
Topics: Animals; Animals, Outbred Strains; Attention; Choice Behavior; Corpus Striatum; Dose-Response Relationship, Drug; Ethylamines; Fluorobenzenes; Impulsive Behavior; Indoles; Male; Microinjections; Piperazines; Piperidines; Prefrontal Cortex; Rats; Reaction Time; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, N-Methyl-D-Aspartate; Serial Learning; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2012 |